Before you can access ASH's online program, you must agree to the following:
Abstracts submitted to the ASH Annual Meeting are
considered embargoed from the time of submission.
For the research and study to be eligible for
presentation at the ASH annual meeting, information
contained in the abstract, as well as additional data
and information to be presented about the research
and/or study at the annual meeting, may not be made
public before the abstract has been published/presented
at the ASH annual meeting.
Last updated January 16, 2009. Please note that this site represents the latest program changes and differs from the print
version in some details.
John C. Byrd1*, Martin S. Tallman, MD2, Joseph M. Connors, MD3, James George, MD4 and Steven L. Allen, MD5
1Division of Hematology/Oncology, Ohio State University, Columbus, OH 2Northwestern University Feinberg School of Medicine, Chicago, IL 3Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada 4University of Oklahoma Health Sciences Center, Oklahoma City, OK 5Medicine, Monter Cancer Center, Lake Success, NY
George R. Buchanan, MD1, Stephen Hunger, MD2, Andrew D. Campbell, MD3 and Steven W. Pipe, MD4
1Southwestern Medical Ctr., University of Texas, Dallas, TX 2Pediatric Heme/Onc/BMT, Univ of Colorado College of Medicine, Aurora, CO 3Pediatric Hematology/Oncology, Univ. of Michigan Med. Ctr., Ann Arbor, MI 4University of Michigan, Ann Arbor, MI
J. Evan Sadler, MD, PhD1, Robert F. Todd III, MD, PhD2, Timothy Ley, MD3, Cynthia Dunbar, MD4* and George F. Atweh, MD5*
1Department of Medicine, Washington University School of Medicine, Saint Louis, MO 2University of Michigan Medical Center, Ann Arbor, MI 3Department of Medicine, Washington University School of Medicine, St. Louis, MO 4National Institutes of Health, Bethesda, MD 5Mount Sinai Medical Center, New York, NY
Robert L. Truitt, PhD1, James Engel, PhD2, Janet Plate, PhD3 and Jerry Ware, PhD4
1Medical College of Wisconsin, Milwaukee, WI 2University of Michigan, Ann Arbor, MI 3Rush Univ. Med. Ctr., Chicago, IL 4University of Arkansas for Medical Sciences, Little Rock, AR
Robert Weinstein, MD1, Randy D. Gascoyne, MD2, Jay Hess, MD, PhD3 and Lawrence Goodnough, MD4
1Univ. of Massachusetts Med. School, UMass Memorial Medical Center, Worcester, MA 2British Columbia Cancer Agency, Vancouver, BC, Canada 3Pathology, University of Michigan, Ann Arbor, MI 4Stanford Univ. School of Med., Palo Alto, CA
Lilli Petruzzelli, MD, PhD1, Nancy Valente, MD2, Allen Ebens, PhD3*, Julie Hambleton, MD2 and John Hohneker4*
1Millennium Pharmaceuticals, Cambridge, MA 2Genentech, South San Francisco, CA 3Translational Oncology, Genentech, South San Francisco, CA 4Novartis, East Hanover, NJ
Susan B. Shurin, MD1, Richard Little2*, Malcolm Smith, MD, PhD3* and Daniel G. Wright, MD4*
1National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 2National Cancer Institute, National Institutes of Health, Bethesda, MD 3Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD 4National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD
![[ Visit Client Website ]](images/banner.gif)